Enterprise Value
75.74M
Cash
45.17M
Avg Qtr Burn
-3.73M
Short % of Float
1.20%
Insider Ownership
2.74%
Institutional Own.
10.90%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
CAP-1002 Details Duchenne muscular dystrophy | Phase 3 Interim Update | |
CAP-1002 Details COVID-19 | Failed Discontinued |